Neurona Therapeutics
SOUTH SAN FRANCISCO, California, United States · Biotechnology
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of
Key facts
- Headquarters
- SOUTH SAN FRANCISCO, California, United States
- Employees
- 91
- Industries
- Biotechnology
- Website
- www.neuronatherapeutics.com
- Company page
Recent activity at Neurona Therapeutics
- : Neurona Therapeutics Appoints Eduardo Dunayevich as Chief Medical Officer
- : NEURONA THERAPEUTICS
- : Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
- : Neurizon Therapeutics Limited, formerly PharmAust Limited, announces its name change and commitment to advancing treatments for neurodegenerative diseases.
- : Neurona Therapeutics Appoints Manher (AJ) Joshi, M.D. as Chief Medical Officer
- : NEURONA THERAPEUTICS
- : NEURONA THERAPEUTICS
- : Neural Therapeutics Inc.
- : NEURONA THERAPEUTICS, INC
- : NEURONA THERAPEUTICS INC
Neurona Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2025 | Venture | $101.7M |
| Feb 2024 | Venture | $120.0M |
| Feb 2022 | Seed | $72.0M |
| Mar 2021 | Venture | $28.3M |
| Nov 2019 | Venture | $15.0M |
Leadership
- Cory Nicholas, Executive Officer, Director
- Tim Kutzkey, Director
- Arnold Kriegstein, Director
- Leo Guthart, Director
- Stephen Hauser, Director
- Robert Tjian, Director
- Erica Whittaker, Director
Verified email and direct lines for Neurona Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Neurona Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Neurona Therapeutics in the news
- NRTX-1001 Shows Seizure Suppression in Preclinical Drug-Resistant Focal Epilepsy Models - NeurologyLive (Nov 27, 2023)
- Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting - GlobeNewswire (Apr 22, 2026)
- uniQure's Mesial Temporal Lobe Epilepsy Gene Therapy AMT-260 Cleared for US Trial - CGTLive® (Sep 08, 2023)
- Cell Therapy NRTX-1001 Posts Positive Preliminary Data in Drug-Resistant Mesial Temporal Lobe Epilepsy - NeurologyLive (Apr 25, 2023)
- Stem Cell News, Parkinson's and Cancer - Live Trading News (Jun 03, 2026)
Companies similar to Neurona Therapeutics
- MindWalk Holdings · Biotechnology
- Pain Specialists of America · Biotechnology
- Beacon Therapeutics · Biotechnology
- Joint Ventures Physical Therapy · Biotechnology
- Ascendia Pharmaceuticals · Biotechnology
About Neurona Therapeutics: questions and answers
What does Neurona Therapeutics do?
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of
Where is Neurona Therapeutics headquartered?
Neurona Therapeutics is headquartered in SOUTH SAN FRANCISCO, California, United States.
How many employees does Neurona Therapeutics have?
Neurona Therapeutics has about 91 employees.
Has Neurona Therapeutics raised funding?
Yes. Fundz has recorded 5 funding events for Neurona Therapeutics. The most recent, $101.7M, was in Apr 2025.
What is the latest news on Neurona Therapeutics?
On Nov 18, 2025, Neurona Therapeutics Appoints Eduardo Dunayevich as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy